Product Description
Value-driven and highlighted for its supreme efficacy, Cetuxa 100 Mg Injection is a sterling option for oncology patients. Procure pristine quality in every vial-containing 100 mg Cetuximab in 20 ml, packaged securely for hospital and clinical use. This chimeric monoclonal antibody targets EGFR, benefiting patients with colorectal and head and neck cancers. For intravenous infusion after dilution, prescription is mandatory. Odorless, clear to pale yellow in appearance, Cetuxa demands precise storage at 2C-8C. Offered by reliable dealers, distributors, and exporters across India, maintaining product excellence at every touchpoint.
Highlighted Medical Application and Surface Use
Cetuxa 100 Mg Injection is precisely designed for intravenous application, making it well-suited for oncology settings such as hospitals and infusion centers. Used predominantly for the treatment of colorectal and head and neck cancers, it acts on the surface of epidermal growth factor receptors (EGFR). Plant application is limited to pharmaceutical production environments, ensuring the sterile preparation and handling necessary for its pristine administration. Its usage represents an advanced intervention in targeted cancer therapy.
Shipping & Markets: FOB Port and Delivery Information
Cetuxa 100 Mg Injection is shipped from prominent Indian FOB ports, catering to both domestic and international markets. Exchanges or quotations are efficiently managed for dealers and healthcare facilities, ensuring prompt responses. The main domestic market includes various regions across India, with delivery times tailored to meet healthcare and logistics requirements. Each batch is procured with the assurance of pristine storage and protection during transit, fulfilling the expectations of suppliers and end-users alike.
FAQ's of Cetuxa 100 Mg Injection:
Q: How should Cetuxa 100 Mg Injection be stored after opening?
A: Once the vial is opened and diluted, Cetuxa 100 Mg Injection should be used immediately or within 24 hours if stored between 2-8C. It must be protected from light and not be frozen.
Q: What conditions is Cetuxa 100 Mg Injection indicated for?
A: Cetuxa 100 Mg Injection is prescribed for patients with colorectal cancer and head and neck cancer, providing targeted therapy against the epidermal growth factor receptor (EGFR).
Q: Where is Cetuxa 100 Mg Injection administered?
A: Cetuxa 100 Mg Injection is administered intravenously, usually in hospitals or oncology centers under the supervision of qualified healthcare professionals.
Q: What are the main side effects of Cetuxa 100 Mg Injection?
A: Common side effects include skin rash, infusion reactions, and low magnesium levels (hypomagnesemia). Healthcare providers monitor these effects during and after administration.
Q: When is a prescription required to procure Cetuxa 100 Mg Injection?
A: A valid prescription from a licensed medical practitioner is mandatory for the procurement and administration of Cetuxa 100 Mg Injection due to its potent therapeutic profile and risks.
Q: How can wholesalers or dealers receive a quotation for this product?
A: Wholesalers, dealers, or healthcare facilities can request a quotation for Cetuxa 100 Mg Injection by contacting authorized distributors or suppliers who will provide details on pricing and supply terms.